aerobic fitness 2: 9
aging and cardiovascular
changes 2: 10
aging and pulmonary changes
2: 181
alveolus 2: 183
anesthesia 4: 262
anthracosis 2: 183
ARDS 2: 181
asbestosis 2: 184
asphyxia 2: 186
atelectasis 2: 190
auscultation 2: 191
berylliosis 2: 192
breathing 2: 193
bronchus 2: 197
byssinosis 2: 198
cardiopulmonary bypass 2: 33
chest percussion and postural
drainage 2: 199
coccidioidomycosis 2: 318
cyanosis 2: 46
drowning 4: 368
dyspnea 2: 203
endurance 4: 220
hantavirus pulmonary syndrome
2:331
hemoptysis 2: 204
histoplasmosis 2: 333
inhaled toxins 4: 384
interstitial lung disorders 2: 205
lung cancer 2: 208
lung transplantation 2: 213
measles 2: 343
overdose 4: 166
oxygen-carbon dioxide
exchange 2: 216
oxygen therapy 2: 217
pleura 2: 218
pleural effusion 2: 218
pleurisy 2: 218
pneumococcal pneumonia 2: 349
pneumonia 2: 220
pneumonitis 2: 222
pneumothorax 2: 223
pulmonary arteries 2: 98
pulmonary edema 2: 223
pulmonary embolism 2:224, 225
pulmonary fibrosis 2: 226
pulmonary hypertension 2: 98
pulmonary veins 2: 99
respiratory failure 2:227–228
silicosis 2:229–230
smoking and pulmonary disease
2:230–231
sputum 2: 231tobacco 4: 353
trachea 2: 233
tracheostomy 2: 234
tuberculosis 2: 359
tuberculosis prevention 4: 49
lung transplantation 2: 213 ,
213–214, 213 t;4: 121
berylliosis 2: 193
COPD 2: 201
oxygen-carbon dioxide
exchange 2: 216
pulmonary fibrosis 2: 226
smoking and pulmonary disease
2: 230
thoracotomy 2: 233
lutein 1:102; 4:79, 79 , 79 t, 107
luteinizing hormone (LH) 3:100,
111, 119, 127, 129, 148, 151, 282
LVEF. Seeleft ventricular ejection
fraction
lycopene 2: 379 t;4: 79 , 79–80, 80 t
Lyme disease 2:341–342, 342 t
lymph 2:120, 123–124, 149,170,
384 , 391. See alsoblood and
lymph
lymphadenitis 2: 120 , 149,151, 155
lymphadenopathy 2:71, 120, 149,
151, 333, 351
lymphangioma 2:149–150
lymphatic capillaries 2:120, 155
lymphatic system 2:134, 152, 245,
343
lymphedema 2: 134 , 150,151, 155
lymph node 2:150–151
lymph 2:120, 149
lymphadenitis 2: 149
lymphadenopathy 2: 149
lymphedema 2: 150
lymph vessels 2: 155
monocyte 2: 157
sentinel lymph node dissection
2:391
spleen 2: 167
T-cell lymphocyte 2: 296
thoracic duct 2: 170
lymphocyte 2:151–152
clusters of differentiation 2:254
graft vs. host disease 2: 263
granulocyte 2: 139
immune system 2:235, 236
immunotherapy 2: 276
leukocyte 2: 119
lymph 2: 120
lymphocytopenia 2: 152
NK cell 2:286
SALT 2: 295spleen 2: 167
TGFs 2: 297
thymectomy 2: 172
thymus 2: 172
VA LT 2: 299
lymphocytopenia 2: 148 , 152
lymphoid tissue 2:236, 287–289
lymphokines 2:280–281
lymphoma 1:150; 2:152–155, 153 t,
154 t;4: 141
adult survivors of childhood
cancer 2: 367
B-cell lymphocyte 2: 251
cancer vaccines 2: 373
carcinogen 2: 374
chemotherapy 2: 377
leukemia 2: 148
lung transplantation 2: 214
lymphadenopathy 2: 149
lymphocyte 2: 152
MALT 2: 284
multiple myeloma 2: 159
myelodysplasia syndrome 2: 160
lymph tissue
antigen 2: 246
BALT 2:251–252
blood stem cells 2: 129
GALT 2:265
immune system 2: 235
lymphocyte 2: 151
MALT 2:284
SALT 2:295
VA LT 2:299
lymph vessels 2:155
aging and changes in
blood/lymph 2: 124
cisterna chyli 2: 134
lymph 2: 149
lymphadenitis 2: 149
lymphangioma 2: 149
lymphedema 2: 150
lymph node 2: 151
right lymphatic duct 2: 165
thoracic duct 2: 170
lysergic acid diethylamide (LSD)
4:170, 328, 337M
MAbs. Seemonoclonal antibodies
macrophage 2:282
aging and immune response
2: 239
antigen 2: 246
BALT 2: 251
cell-mediated immunity 2: 253
chemokines 2: 253486 Index